// App-Quantinova.ai

BS15 : In vivo whole body fluorescence molecular imaging of experimental atherosclerosis using anti malondialdehyde modified low density lipoprotein humanised antibody fragment targeted nanoparticles

Researchers

Presenter

  • Adam Hartley

Principal Investigators

  • Michelle Greene

  • Mikhail Caga-Anan

  • Samuel Owen

  • Michael Mullin

  • Charis Pericleous

  • Chris Scott

  • Justin Mason

  • Dorian Haskard

  • Ramzi Khamis

Medical Centers

  • Imperial College London, Vascular Sciences, 5th floor, ICTEM, Hamm, London, LND W12 0NN UK

  • Queens University, Belfast, UK

  • Imperial College, London, UK

  • GSK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A